200 - 200 Episodes, One Big Conversation: Dr. Aron Sousa on RFU and Community Impact
In this milestone 200th episode of HelixTalk, we interview Dr. Aron Sousa, President and CEO of Rosalind Franklin University, about his care...
Radio and PodcastLive Radio & Podcasts
Science & Medicine
HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast
Educational podcast presented by the Rosalind Franklin University College of Pharmacy. This podcast is produced by our pharmacy faculty to supplement study material and provide relevant drug...
Episodes
20 of 214 episodes
199 - Axe the Anaerobes, Drop the Docuste, Free the Fluids
In this episode, we review three medical myths, highlighted in the "Things We Do For No Reason" series of the Journal of Hospital Medicine,...
198 - Lp(a), ApoB, and CAC: Navigating the 2026 Dyslipidemia Guideline Alphabet Soup
In this episode, we review key updates from the 2026 ACC-AHA Guidelines on the Management of Dyslipidemia. Key Concepts The PREVENT ASCVD eq...
197 - Sweet Deal of Updates in Diabetes Pharmacotherapy from the ADA 2026 Standards of Care
In this episode, we discuss the most important annual updates in the American Diabetes Association Guidelines, Standards of Care 2026, parti...
196 - Stretching the Stroke Clock to 2026: A Brief Review of the 2026 Acute Ischemic Stroke Guidelines
In this episode, we review key updates from the 2026 AHA/ASA Guideline for the Early Management of Patients With Acute Ischemic Stroke, incl...
195 - Burning Questions about Uncomplicated UTI Diagnosis and Treatment
In this episode, we review the clinical presentation, diagnosis, and treatment of uncomplicated urinary tract infections. Key Concepts Uncom...
194 - 5-HT3 Receptor Antagonists for Nausea/Vomiting: An In-Depth Drug Class Review
In this episode, we review the pharmacology, indications, adverse effects, and unique drug characteristics of 5-HT3 receptor antagonists suc...
193 - Elevate Your Guideline Knowledge, Not Your BP: The New 2025 Hypertension Guidelines
In this episode, we review the newly published 2025 ACC/AHA hypertension guidelines. Key Concepts Instead of the Pooled Cohort Equations (PC...
192 - Opioids Optional: Journavx, the New Acute Pain Management Alternative
In this episode, we discuss the evidence, safety, and place in therapy of Journavx® (suzetrigine), a newly approved analgesic with a unique...
191 - The Ultimate Guide to ARBs: An In-depth Drug Class Review
In this episode, we review the pharmacology, indications, adverse effects, monitoring, and unique drug characteristics of angiotensin recept...
190 - Can't Stop, Won't Drop … The BP That Just Won't Quit: Diagnosis and Treatment of Resistant Hypertension
In this episode, we discuss the diagnosis and treatment of resistant hypertension, including a newer endothelin receptor antagonist (ERA) ca...
189 - Mice, Macrophages, and Metabolism: Browning Keeps Obesity at Bay
In this episode, we discuss the very early stages of drug targets and drug development with Dr. Mohd Shahid, PhD. Dr. Shahid's research invo...
188 - The Clot Thickens: Key Updates from the 2025 Acute Coronary Syndromes Guidelines
In this episode, we review the new 2025 ACC/AHA Acute Coronary Syndrome (ACS) guidelines, with a particular focus on guideline recommendatio...
187 - Infectious Ambitions: A Pharmacist's Career Pivot from Clinical to Industry
In this episode, we interview Morgan Anderson, PharmD, BCIDP, a graduate of the RFUMS College of Pharmacy, about her career path from a phar...
186 - Breaking the Bank or Breaking the Scale: Controversies Surrounding Compounded GLP-1s RAs for Weight Loss
In this episode, we discuss the efficacy and safety of semaglutide and tirzepatide for weight loss with a particular focus on the legal, reg...
185 - They Are Late, but Don't Stress: The New 2024 Stress Ulcer Prophylaxis Guidelines
In this episode, we review the recommendations from the 2024 SCCM/ASHP stress ulcer prophylaxis guidelines and highlight three of the more r...
184 - Drop it Like it's Hot! Deprescribing Pharmacotherapy When Appropriate
In this episode, we discuss the approach to deprescribing for several drugs such as benzodiazepine receptor agonists, cholinesterase inhibit...
183 - The Ultimate Guide to Loop Diuretics: An In-Depth Drug Class Review
In this episode, we review the pharmacology, pharmacokinetics, adverse effects, monitoring, medicinal chemistry, and more of loop diuretics....
182 - 2023 Beers Criteria Update: Navigating Medications Safely in Older Patients
In this episode, we discuss principles for medication use in the geriatric patient population and summarize the updated 2023 American Geriat...
181 - From Meds to Machine Learning: How AI is (and will) Revolutionizing Pharmacy Practice
In this episode, we discuss artificial intelligence large language models (LLMs) and how these will impact the future of the practice of pha...